Holding(s) in Company

Summary by AI BETAClose X

UBS Group AG, acting on behalf of UBS AG, notified a 5.046062% acquisition of voting rights in Renalytix PLC (GB00BYWL4Y04) on August 20, 2025, resulting in a total holding of 16,712,860 voting rights. This notification was submitted on August 22, 2025. The acquisition consisted solely of direct voting rights attached to shares; no financial instruments were involved.

Disclaimer*

UK 100

Latest directors dealings